Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation

Circulation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/13/4″>Volume 13, Issue 4</a>, April 1, 2020.

Source link